Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Peripheral Arterial Disease D058729 7 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Farber Lipogranulomatosis D055577 1 associated lipids
Acute Lung Injury D055371 33 associated lipids
Lung Injury D055370 14 associated lipids
Niemann-Pick Disease, Type C D052556 1 associated lipids
Atherosclerosis D050197 85 associated lipids
Ileus D045823 3 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Endotoxemia D019446 27 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Proia RL and Hla T Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy. 2015 J. Clin. Invest. pmid:25831442
Lee SY et al. Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice. 2015 Hepatology pmid:25808625
Salama MF et al. A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma. 2015 FASEB J. pmid:25805832
Zhang L et al. Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer. 2015 Clin. Cancer Res. pmid:25589614
Chavez A et al. S1PR1 Tyr143 phosphorylation downregulates endothelial cell surface S1PR1 expression and responsiveness. 2015 J. Cell. Sci. pmid:25588843
Woszczek G and Fuerst E Ca2+ mobilization assays in GPCR drug discovery. 2015 Methods Mol. Biol. pmid:25563178
Kurek K et al. Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance. 2015 J Diabetes Res pmid:26380311
Zhao C et al. Chemical Hypoxia Brings to Light Altered Autocrine Sphingosine-1-Phosphate Signalling in Rheumatoid Arthritis Synovial Fibroblasts. 2015 Mediators Inflamm. pmid:26556954
Frej C et al. Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation. 2015 Anal Bioanal Chem pmid:26377937
Wang H et al. Sphingosine-1-Phosphate Induces the Migration and Angiogenesis of Epcs Through the Akt Signaling Pathway via Sphingosine-1-Phosphate Receptor 3/Platelet-Derived Growth Factor Receptor-β. 2015 Cell. Mol. Biol. Lett. pmid:26208383
Manes NP et al. Targeted Proteomics-Driven Computational Modeling of Macrophage S1P Chemosensing. 2015 Mol. Cell Proteomics pmid:26199343
Spampinato SF et al. Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli? 2015 PLoS ONE pmid:26197437
Morad SA and Cabot MC Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications. 2015 Biochim. Biophys. Acta pmid:25964209
Jing XD et al. The relationship between the high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) and coronary in-stent restenosis. 2015 Clin. Chim. Acta pmid:25958848
Laurenzana A et al. Endothelial sphingosine kinase/SPNS2 axis is critical for vessel-like formation by human mesoangioblasts. 2015 J. Mol. Med. pmid:25952146
Rahman MM et al. Secretion of PDGF isoforms during osteoclastogenesis and its modulation by anti-osteoclast drugs. 2015 Biochem. Biophys. Res. Commun. pmid:25951977
Rao PV Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma. 2014 Mar-Apr J Ocul Pharmacol Ther pmid:24283588
Roviezzo F et al. Involvement of proteinase activated receptor-2 in the vascular response to sphingosine 1-phosphate. 2014 Clin. Sci. pmid:24131465
Qin Z et al. Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma. 2014 Mol. Cancer Ther. pmid:24140934
Ryu JM et al. Sphingosine-1-phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent β-arrestin/c-Src pathways. 2014 Stem Cell Res pmid:24145189
Uhlig S et al. Differential regulation of lung endothelial permeability in vitro and in situ. 2014 Cell. Physiol. Biochem. pmid:24977477
Meng Y et al. Sphingosine-1-phosphate suppresses cyclophosphamide induced follicle apoptosis in human fetal ovarian xenografts in nude mice. 2014 Fertil. Steril. pmid:24993801
Kang JW and Lee SM Impaired expression of caveolin-1 contributes to hepatic ischemia and reperfusion injury. 2014 Biochem. Biophys. Res. Commun. pmid:24997335
Chen J et al. Spinster homolog 2 (spns2) deficiency causes early onset progressive hearing loss. 2014 PLoS Genet. pmid:25356849
Degagné E et al. Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs. 2014 J. Clin. Invest. pmid:25347472
Wang F and Ye P Improving heart function by modulating myocardiocyte autophagy: a possible novel mechanism for cardiovascular protection of high-density lipoprotein. 2014 Lipids Health Dis pmid:25339382
Keller J et al. Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts. 2014 Nat Commun pmid:25333900
Sasaki H et al. Regulation of alkaline ceramidase activity by the c-Src-mediated pathway. 2014 Arch. Biochem. Biophys. pmid:24708996
Ntranos A et al. FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway. 2014 J. Neuroimmunol. pmid:24680062
Liu M et al. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein. 2014 J. Biol. Chem. pmid:24318881
Li F et al. Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death. 2014 Hum. Reprod. pmid:24221908
Bigaud M et al. Second generation S1P pathway modulators: research strategies and clinical developments. 2014 Biochim. Biophys. Acta pmid:24239768
Huang YL et al. Extrinsic sphingosine 1-phosphate activates S1P5 and induces autophagy through generating endoplasmic reticulum stress in human prostate cancer PC-3 cells. 2014 Cell. Signal. pmid:24333325
Nguyen AV et al. STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer. 2014 World J. Gastroenterol. pmid:25132744
Deng Y et al. Sphingosine Kinase-1/sphingosine 1-phosphate pathway in diabetic nephropathy. 2014 Chin. Med. J. pmid:25131242
Ogle ME et al. Engineering in vivo gradients of sphingosine-1-phosphate receptor ligands for localized microvascular remodeling and inflammatory cell positioning. 2014 Acta Biomater pmid:25128750
Tong X et al. The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus. 2014 Cardiovasc Diabetol pmid:24751283
Halmer R et al. Sphingolipids: important players in multiple sclerosis. 2014 Cell. Physiol. Biochem. pmid:24977485
Arlt O et al. Sphingosine-1-phosphate modulates dendritic cell function: focus on non-migratory effects in vitro and in vivo. 2014 Cell. Physiol. Biochem. pmid:24977479
Don AS et al. Re-configuration of sphingolipid metabolism by oncogenic transformation. 2014 Biomolecules pmid:24970218
Snelder N et al. Translational pharmacokinetic modeling of fingolimod (FTY720) as a paradigm compound subject to sphingosine kinase-mediated phosphorylation. 2014 Drug Metab. Dispos. pmid:24965813
Zhang J and Song J Amphiphilic degradable polymers for immobilization and sustained delivery of sphingosine 1-phosphate. 2014 Acta Biomater pmid:24631657
Priceman SJ et al. S1PR1 is crucial for accumulation of regulatory T cells in tumors via STAT3. 2014 Cell Rep pmid:24630990
Oizumi A et al. Pseudomonas-derived ceramidase induces production of inflammatory mediators from human keratinocytes via sphingosine-1-phosphate. 2014 PLoS ONE pmid:24586752
Guan Z et al. Sphingosine-1-phosphate evokes unique segment-specific vasoconstriction of the renal microvasculature. 2014 J. Am. Soc. Nephrol. pmid:24578134
Borge M et al. The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406. 2014 J. Immunol. pmid:25127862
Egom EE Sphingosine-1-phosphate signalling as a therapeutic target for patients with abnormal glucose metabolism and ischaemic heart disease. 2014 J Cardiovasc Med (Hagerstown) pmid:23839592
Cencetti F et al. Lysophosphatidic acid stimulates cell migration of satellite cells. A role for the sphingosine kinase/sphingosine 1-phosphate axis. 2014 FEBS J. pmid:25131845
Xia JY et al. The adipokine/ceramide axis: key aspects of insulin sensitization. 2014 Biochimie pmid:23969158
Albinet V et al. Dual role of sphingosine kinase-1 in promoting the differentiation of dermal fibroblasts and the dissemination of melanoma cells. 2014 Oncogene pmid:23893239